Algert Global LLC Assembly Biosciences, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.35 - $2.29 $6,588 - $11,175	4,880 Added 13.19%	41,890 $88,000
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $54,034 - $90,674	37,010 New	37,010 $76,000
Q2 2020 Aug 12, 2020	SELL	$14.57 - $23.96 $167,700 - $275,779	-11,510 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$10.27 - $21.23 $118,207 - $244,357	11,510 New	11,510 $171,000
Q4 2019 Feb 18, 2020	SELL	$8.36 - $23.81 $135,039 - $384,602	-16,153 Closed	0 $0

Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $25,970 - $39,154	2,642 Added 19.55%	16,153 $159,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $174,291 - $281,028	13,511 New	13,511 $182,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.